Systagenix Acquires O2 Insights Inc, Adding a Third Marker to its Wound Diagnostics Pipeline
- Wed, 6/13/12 - 10:25am
- 0 Comments
- 579 reads
Systagenix (Gatwick, UK) completed the acquisition of the assets of O2 Insights Inc (Columbus, OH). Co-founded by Robert Rushenberg and Dr. Samit Gupta, PhD, O2 Insights Inc is a technology start-up developing rapid, reliable, and cost effective point-of-care diagnostics for the measurement of transcutaneous tissue oxygenation.
O2 Insights’ technology aims to address many of the shortcomings of current Transcutaneous oxygen perfusion measurement (TCOM) devices, which can be complex to operate, take up to 45 minutes to generate a result, and can require a dedicated technician to operate. The O2 Insights Inc. technology holds the promise of providing easy to use, accurate, and reliable TCOMs in a matter of minutes and at significantly lower capital equipment cost, thus making measurement of TcpO2 accessible to much larger numbers of patients and health care providers in various clinical settings.
Visit http://www.systagenix.com for more information.